Compare AXIL & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AXIL | MYO |
|---|---|---|
| Founded | 2015 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.4M | 36.9M |
| IPO Year | 2017 | 2017 |
| Metric | AXIL | MYO |
|---|---|---|
| Price | $5.75 | $0.69 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $7.67 |
| AVG Volume (30 Days) | 8.7K | ★ 412.0K |
| Earning Date | 01-01-0001 | 06-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.13 | N/A |
| Revenue | $26,257,522.00 | ★ $1,000,000,000.00 |
| Revenue This Year | N/A | $15.92 |
| Revenue Next Year | N/A | $21.49 |
| P/E Ratio | $43.77 | ★ N/A |
| Revenue Growth | N/A | ★ 40814.79 |
| 52 Week Low | $4.04 | $0.64 |
| 52 Week High | $10.25 | $5.62 |
| Indicator | AXIL | MYO |
|---|---|---|
| Relative Strength Index (RSI) | 44.29 | 39.44 |
| Support Level | $4.76 | $0.68 |
| Resistance Level | $6.25 | $1.03 |
| Average True Range (ATR) | 0.52 | 0.07 |
| MACD | -0.04 | -0.00 |
| Stochastic Oscillator | 26.48 | 25.21 |
AXIL Brands Inc is a company which is is a manufacturer and marketer of premium hearing enhancement and protection products, including ear plugs, earmuffs, and ear buds, and outdoor speakers, under the AXIL brand. AXIL delivers top hearing enhancement, protection, & audio devices. From ultra comfortable fitting processes, to stereo quality sound performance, to reliable & durable engineering. The company operates two operating segments: hearing enhancement and protection, and hair and skin care.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).